Gergely Kriván

2.0k total citations
58 papers, 449 citations indexed

About

Gergely Kriván is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gergely Kriván has authored 58 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 24 papers in Immunology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gergely Kriván's work include Immunodeficiency and Autoimmune Disorders (15 papers), Acute Lymphoblastic Leukemia research (8 papers) and Complement system in diseases (7 papers). Gergely Kriván is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (15 papers), Acute Lymphoblastic Leukemia research (8 papers) and Complement system in diseases (7 papers). Gergely Kriván collaborates with scholars based in Hungary, Germany and United States. Gergely Kriván's co-authors include Krisztián Kállay, János Sinkó, Vera Goda, Regina Dutkowski, Michal Shapira, Péter Szakály, Michael G. Ison, Katalin Csordás, Ewa Bernatowska and Stephen Jolles and has published in prestigious journals such as Blood, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Gergely Kriván

48 papers receiving 441 citations

Peers

Gergely Kriván
Gergely Kriván
Citations per year, relative to Gergely Kriván Gergely Kriván (= 1×) peers Laurence Clément

Countries citing papers authored by Gergely Kriván

Since Specialization
Citations

This map shows the geographic impact of Gergely Kriván's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gergely Kriván with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gergely Kriván more than expected).

Fields of papers citing papers by Gergely Kriván

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gergely Kriván. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gergely Kriván. The network helps show where Gergely Kriván may publish in the future.

Co-authorship network of co-authors of Gergely Kriván

This figure shows the co-authorship network connecting the top 25 collaborators of Gergely Kriván. A scholar is included among the top collaborators of Gergely Kriván based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gergely Kriván. Gergely Kriván is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Čižnár, Peter, Marion Roderick, Miloš Jeseňák, et al.. (2024). fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study. Allergy Asthma and Clinical Immunology. 20(1). 47–47. 1 indexed citations
2.
Székely, Gábor J., Vera Goda, Krisztián Kállay, et al.. (2023). Chromosomal breakage tests in the differential diagnosis of Fanconi anemia and aplastic anemia. European Journal Of Haematology. 111(2). 254–262. 2 indexed citations
3.
Karászi, Éva, János Szlávik, Vera Goda, et al.. (2023). Infekciók kockázatának csökkentése veleszületett és szerzett komplementdefektusokban.. Orvosi Hetilap. 164(25). 971–980. 1 indexed citations
5.
Goda, Vera, Gergely Kriván, Zsolt Matula, et al.. (2022). Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency. Frontiers in Immunology. 13. 907125–907125. 10 indexed citations
6.
Kriván, Gergely, Michael Borte, Pere Soler‐Palacín, et al.. (2022). BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children. Journal of Clinical Immunology. 43(3). 557–567. 2 indexed citations
7.
Reusz, György, Vera Goda, István Balogh, et al.. (2021). Non-lupus full-house nephropathy—immune dysregulation as a rare cause of pediatric nephrotic syndrome: Questions. Pediatric Nephrology. 37(5). 1049–1051. 2 indexed citations
8.
Reusz, György, Vera Goda, István Balogh, et al.. (2021). Non-lupus full-house nephropathy—immune dysregulation as a rare cause of pediatric nephrotic syndrome: Answers. Pediatric Nephrology. 37(5). 1053–1056.
9.
Morland, Bruce, Tomáš Kepák, Sandro Dallorso, et al.. (2020). Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC). Bone Marrow Transplantation. 55(9). 1744–1753. 19 indexed citations
10.
Jakab, Zsuzsanna, Miklós Garami, Monika Csóka, et al.. (2020). Late mortality in survivors of childhood cancer in Hungary. Scientific Reports. 10(1). 10761–10761. 4 indexed citations
12.
Czyźewski, K, Petr Sedláček, Jaroslav Štěrba, et al.. (2020). Progress and trends in pediatric hematopoietic cell transplantation in Central-East European countries. Acta Haematologica Polonica. 51(3). 142–150. 8 indexed citations
13.
Kállay, Krisztián, et al.. (2018). Antithymocyte Globuline Therapy and Bradycardia in Children. Pathology & Oncology Research. 25(2). 487–492. 2 indexed citations
14.
Kriván, Gergely, Larysa Kostyuchenko, Andrzej Lange, et al.. (2017). A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency. Journal of Clinical Immunology. 37(6). 539–547. 10 indexed citations
15.
Szönyi, László, Gergely Kriván, György Reusz, et al.. (2014). Post-transplant lymphoproliferative disorder in childhood. Orvosi Hetilap. 155(8). 313–318.
16.
Kállay, Krisztián, et al.. (2012). Successful unrelated umbilical cord blood transplantation in Lesch-Nyhan syndrome. Metabolic Brain Disease. 27(2). 193–196. 10 indexed citations
17.
Blijlevens, Nicole, Gergely Kriván, Werner Rabitsch, et al.. (2012). In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden. Bone Marrow Transplantation. 48(7). 966–971. 36 indexed citations
18.
Haltrich, Irén, Maria Kost‐Alimova, Gábor Kovács, et al.. (2005). Jumping translocation of 17q11∼qter and 3q25∼q28 duplication in a variant Philadelphia t(9;14;22)(q34;q32;q11) in a childhood chronic myelogenous leukemia. Cancer Genetics and Cytogenetics. 164(1). 74–80. 8 indexed citations
19.
Hermann, Péter, et al.. (2005). Incidence of Oropharyngeal Candidosis in Stem Cell Transplant (SCT) Patients. Acta Microbiologica et Immunologica Hungarica. 52(1). 85–94. 3 indexed citations
20.
Kriván, Gergely, et al.. (1991). [Hyperimmunoglobulinemia E (Job) syndrome].. PubMed. 132(7). 369–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026